| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |